SB 844: Sickle Cell Disease Care Management and Treatment Continuing Education
GENERAL BILL by Jones
Sickle Cell Disease Care Management and Treatment Continuing Education; Revising requirements for a continuing education course on prescribing controlled substances which health care practitioners are required to complete; requiring the applicable licensing boards for specified health care professions to require a 2-hour continuing education course on sickle cell disease care management as part of the first licensure or certification renewal; specifying requirements for the course; authorizing the applicable boards to approve additional equivalent courses to satisfy the requirement, etc.
Last Action: 2/3/2026 Senate - Now in Appropriations Committee on Health and Human Services
Bill Text: Web Page | PDF
-
Bill History
Date Chamber Action 12/10/2025 Senate • Filed
12/16/2025 Senate • Referred to Health Policy; Appropriations Committee on Health and Human Services; Fiscal Policy
1/13/2026 Senate • Introduced
1/28/2026 Senate • On Committee agenda-- Health Policy, 02/02/26, 3:30 pm, 412 Knott Building
2/2/2026 Senate • Favorable by Health Policy; YEAS 11 NAYS 0
2/3/2026 Senate • Now in Appropriations Committee on Health and Human Services
-
SB 844, Original Filed Version (Current Bill Version) Posted 12/10/2025 at 8:14 AM
Bill Text: Web Page | PDF Analyses: Health Policy (Pre-Meeting) 1/30/2026 (pdf)
Health Policy (Post-Meeting) 2/3/2026 (pdf)
Related Bills (1)
Bill Number Subject Filed By Relationship Last Action and Location Track Bills H 353 Sickle Cell Care Management and Treatment Continuing Education Robinson Identical Last Action: 1/13/2026 H 1st Reading (Original Filed Version) 
Committee Votes (1)
Date Committee Result 2/2/2026 3:30 PM Health Policy 11 Yeas - 0 Nays Citations - Statutes (2)
Citation Catchline Location in Bill Location In Bill Help 456.0301 Requirement for instruction on controlled substance prescribing. Page 2 (pdf) 456.0311 Page 3 (pdf)